Predict your next investment

HEALTHCARE | Drug Development

See what CB Insights has to offer

Founded Year



Acquired | Acquired

About Alvos Therapeutics

Alvos Therapeutics is a biopharmaceutical provider to use in vivo phage display technology systematically to develop novel cancer drugs. Alvos was founded to translate the research into effective cancer therapeutics. The company is formerly known as Mercator Therapeutics, Inc.In April 2012, Alvos Therapeutics was acquired by Arrowhead Research. The valuation of Alvos Therapeutics was undisclosed. Other terms of the deal were not released.

Alvos Therapeutics Headquarter Location

Wellesley, Massachusetts,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Alvos Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Alvos Therapeutics is included in 3 Expert Collections, including Pharma Startups.


Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.


Cancer Therapeutics

1,179 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.



3,604 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.